Cluster Headache Clinical Trials

8 recruitingLast updated: May 5, 2026

There are 12 actively recruiting cluster headache clinical trials across 11 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4. Top locations include Leiden, Netherlands, Marseille, France, Nijmegen, Netherlands. Updated daily from ClinicalTrials.gov.


Cluster Headache Trials at a Glance

12 actively recruiting trials for cluster headache are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Leiden, Marseille, and Nijmegen. Lead sponsors running cluster headache studies include IRCCS National Neurological Institute "C. Mondino" Foundation, Karolinska Institutet, and Assistance Publique Hopitaux De Marseille.

Browse cluster headache trials by phase

Treatments under study

About Cluster Headache Clinical Trials

Looking for clinical trials for Cluster Headache? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cluster Headache trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cluster Headache clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 2

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

MigraineCluster HeadacheCraniofacial Pain+3 more
Stanford University15 enrolled1 locationNCT04930887
Recruiting
Not Applicable

Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache

Chronic Cluster Headache
Salvia BioElectronics10 enrolled1 locationNCT07113470
Recruiting

The Will Erwin Headache Research Center - Cluster Headache Study

Trigeminal NeuralgiaCluster HeadacheCluster Headaches and Other Trigeminal Autonomic Cephalgias+3 more
The University of Texas Health Science Center, Houston1,500 enrolled1 locationNCT02910323
Recruiting
Not Applicable

Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study

migraine headacheCluster Headaches and Other Trigeminal Autonomic CephalgiasMigraine Headaches+4 more
Karolinska Institutet40 enrolled1 locationNCT07292090
Recruiting
Phase 3

Repeated GON Injections in CCH

Cluster Headache
Leiden University Medical Center50 enrolled2 locationsNCT05324748
Recruiting

China Headache and Vertigo Registry Study

Tension-type headacheFibromyalgiaMigraine+5 more
Second Affiliated Hospital, School of Medicine, Zhejiang University10,000 enrolled1 locationNCT04939922
Recruiting
Phase 4

Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)

Refractory Chronic Cluster Headache
University Hospital, Clermont-Ferrand90 enrolled14 locationsNCT04814381
Recruiting
Phase 2

LSD to Improve Cluster Headache Impact Trial

Chronic Cluster Headache
Radboud University Medical Center65 enrolled2 locationsNCT05477459
Recruiting
Not Applicable

Efficacy of Light Therapy in Treatment of Chronic Cluster Headache

Cluster Headache
Assistance Publique Hopitaux De Marseille48 enrolled2 locationsNCT06540651
Recruiting
Phase 2

Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache

Cluster Headache
University Hospital, Basel, Switzerland30 enrolled1 locationNCT03781128
Recruiting
Phase 3

Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache

Cluster Headache
Norwegian University of Science and Technology112 enrolled5 locationsNCT03944876
Recruiting

Role of Specific microRNAs in Cluster Headache

Cluster Headache
IRCCS National Neurological Institute "C. Mondino" Foundation100 enrolled1 locationNCT06503328